Clinical trials
Active, not recruiting Observational Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Antalya Training and Research Hospital | 1 |
| Dent Neuroscience Research Center | 1 |
| Novartis Pharmaceuticals | 1 |
| University of Colorado, Denver | 1 |
| Uppsala University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 7 |
| Multiple Sclerosis | 4 |
| Disease Progression | 1 |
| Macular Edema | 1 |
| Malnutrition | 1 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Neoplasms | 1 |
| Urinary Incontinence | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.